DNA sequencing technology developer Stratos Genomics, a spinoff from Stratos Group, also counts Roche Ventures as a backer.
Stratos Genomics, a US-based DNA sequencing technology developer backed by pharmaceutical firm Roche, has secured $20m in funding from venture capital firm Fisk Ventures.
Spun off from technology development services provider Stratos Group in 2007, Stratos Genomics is developing a DNA sequencing process called Sequencing By Expansion, which encodes the sequence of a DNA molecule into a measurable surrogate it calls an Xpandomer.
The funding will be used to finalise development of the company’s technology as it prepares for commercial…
